Impaired fasting glucose, ancestry and waist-to-height ratio: Main predictors of incident diagnosed diabetes in the Canary Islands

Diabetic Medicine

Volumn 29, Issue 3, 2012, Pages 399-403

  Cabrera de Leon A ^a,b   Dominguez Coello S ^a   Almeida Gonzalez D ^a   Brito Diaz B ^a   del Castillo Rodriguez J C ^c   Gonzalez Hernandez A ^a   Aguirre Jaime, A ^a   del Cristo Rodriguez Perez M ^a  

^a HOSPITAL UNIVERSITARIO NUESTRA SEÑORA DE CANDELARIA   (Spain)

^b UNIVERSIDAD DE LA LAGUNA   (Spain)

^c San Juan de Dios Hospital   (Spain)

Author keywords

Ancestry; Diabetes; Epidemiology; Impaired fasting glucose; Obesity

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; TRIACYLGLYCEROL;

ADULT; AGED; ALCOHOL CONSUMPTION; ANTHROPOMETRIC PARAMETERS; ARTICLE; BODY MASS; CLINICAL ASSESSMENT; DIABETES MELLITUS; ETHNIC GROUP; FEMALE; HAZARD RATIO; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MEDITERRANEAN DIET; METABOLIC SYNDROME X; PREDICTION; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; SEDENTARY LIFESTYLE; SMOKING; SOCIAL CLASS; WAIST HEIGHT RATIO;

ADULT; AGED; ALCOHOL DRINKING; BLOOD GLUCOSE; BODY HEIGHT; BODY MASS INDEX; DIET, MEDITERRANEAN; FASTING; FEMALE; FOLLOW-UP STUDIES; GLUCOSE INTOLERANCE; HUMANS; INCIDENCE; LONGITUDINAL STUDIES; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; PEDIGREE; POPULATION SURVEILLANCE; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; SEDENTARY LIFESTYLE; SMOKING; SOCIAL CLASS; SPAIN; WAIST CIRCUMFERENCE;

EID: 84857351842     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2011.03420.x     Document Type: Article

References (26)

1. Grau M, Elosua R, Cabrera de León A, Guembe MJ, Baena-Díez JM, Vega Alonso T et al. Cardiovascular risk factors in Spain in the first decade of the 21st century, a pooled analysis with individual data from 11 population-based studies: the DARIOS Study. Rev Esp Cardiol 2011; 64: 295-304.
2. Centro Nacional de Epidemiología. Mortalidad por Causa, Sexo y Comunidad Autónoma. Tasas ajustadas por edad (Mortality by cause, gender and Autonomous Community. Age adjusted rates). Available at Last accessed 8 April 2011.
3. de Pablos-Velasco PL, Martínez-Martín FJ, Molero R, Rodríguez-Pérez F, García-Puente I, Caballero A. Patterns of prescription of hypoglycaemic drugs in Gran Canaria (Canary Islands, Spain) and estimation of the prevalence of diabetes mellitus. Diabetes Metab 2005; 3: 457-462.
4. Cabrera de León A, del Castillo Rodríguez JC, Domínguez Coello S, Rodríguez Pérez MC, Brito Díaz B, Borges Álamo C et al. Lifestyle and treatment adherence of type2 diabetes mellitus people in the Canary Islands. Rev Esp Salud Pública 2009; 83: 567-575.
5. Orozco-Beltrán D, Gil-Guillen VF, Quirce F, Navarro-Perez J, Pineda M, Gomez-de-la-Cámara A et al.; Collaborative Diabetes Study Investigators Control of diabetes and cardiovascular risk factors in patients with type2 diabetes in primary care. The gap between guidelines and reality in Spain. Int J Clin Pract 2007; 6: 909-915.
6. Resnick HE, Foster GL, Bardsley J, Ratner RE. Achievement of American Diabetes Association clinical practice recommendations among US adults with diabetes, 1999-2002: the National Health and Nutrition Examination Survey. Diabetes Care 2006; 29: 531-537.
7. Maca-Meyer N, Villar J, Pérez-Méndez L, Cabrera de León A, Flores C. A tale of aborigines, conquerors and slaves: Alu insertion polymorphisms and the peopling of the Canary Islands. Ann Hum Genet 2004; 68: 600-605.
8. Cabrera de León A, Rodríguez Pérez MC, Almeida González D, Domínguez Coello S, Aguirre Jaime A, Brito Díaz B, et al.; Grupo CDC. Presentation of the 'CDC de Canarias' cohort: objectives, design and preliminary results. Rev Esp Salud Pública 2008; 82: 519-534.
9. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009; 120: 1640-1645.
10. Rodríguez Pérez MC, Cabrera de León A, Aguirre-Jaime A, Domínguez Coello S, Brito Díaz B, Almeida González D et al. The waist-to-height ratio as an index of cardiovascular risk and diabetes. Med Clin (Barc) 2010; 134: 386-391.
11. McLaughlin T, Abbasi F, Cheal K, Chu J, Lamendola C, Reaven G. Use of metabolic markers to identify overweight individuals who are insulin resistant. Ann Intern Med 2003; 139: 802-809.
12. Cabrera de León A, Rodríguez Pérez MC, Rodríguez Benjumeda LM, Anía Lafuente B, Brito Díaz B, Muros de Fuentes M et al. Sedentary lifestyle: physical activity duration versus percentage of energy expenditure. Rev Esp Cardiol 2007; 69: 244-250.
13. Trichopoulou A, Costacou T, Bamia C, Trichopoulos D. Adherence to a Mediterranean diet and survival in a Greek population. N Engl J Med 2003; 348: 2599-2608.
14. Cabrera de León A, Rodríguez Pérez MC, Domínguez Coello S, Rodríguez Díaz C, Rodríguez Alvarez C, Aguirre Jaime A, Grupo CDC. Validation of the ICE model to assess social class in the adult population. Rev Esp Salud Publica 2009; 83: 231-242.
15. Arteagoitia JM, Larrañaga MI, Rodriguez JL, Fernandez I, Piniés JA. Incidence, prevalence and coronary heart disease risk level in known type2 diabetes: a sentinel practice network study in the Basque Country, Spain. Diabetologia 2003; 46: 899-809.
16. González EL, Johansson S, Wallander MA, Rodríguez LA. Trends in the prevalence and incidence of diabetes in the UK: 1996-2005. J Epidemiol Community Health 2009; 63: 332-336.
17. Valdés S, Botas P, Delgado E, Alvarez F, Cadórniga FD. Population-based incidence of type2 diabetes in northern Spain: the Asturias Study. Diabetes Care 2007; 30: 2258-2263.
18. Liu SJ, Guo ZR, Hu XS, Wu M, Chen FM, Kang GD et al. Risks for type2 diabetes associated with the metabolic syndrome and the interaction between impaired fasting glucose and other components of metabolic syndrome the study from Jiangsu, China of 5years' follow-up. Diabetes Res Clin Pract 2008; 8: 117-123.
19. Wang H, Shara NM, Calhoun D, Umans JG, Lee ET, Howard BV. Incidence rates and predictors of diabetes in those with prediabetes: the Strong Heart Study. Diabetes Metab Res Rev 2010; 26: 378-385.
20. MacKay MF, Haffner SM, Wagenknecht LE, D'Agostino RB Jr, Hanley AJ. Prediction of type2 diabetes using alternate anthropometric measures in a multi-ethnic cohort: the insulin resistance atherosclerosis study. Diabetes Care 2009; 32: 956-958.
21. Meigs JB, Rutter MK, Sullivan LM, Fox CS, D'Agostino RB Sr, Wilson PW. Impact of insulin resistance on risk of type2 diabetes and cardiovascular disease in people with metabolic syndrome. Diabetes Care 2007; 30: 1219-1225.
22. Browning LM, Hsieh SD, Ashwell M. A systematic review of waist-to-height ratio as a screening tool for the prediction of cardiovascular disease and diabetes: 0.5 could be a suitable global boundary value. Nutr Res Rev 2010; 23: 247-269.
23. Cameron AJ, Magliano DJ, Zimmet PZ, Welborn TA, Colagiuri S, Tonkin AM et al. The metabolic syndrome as a tool for predicting future diabetes: the AusDiab study. J Intern Med 2008; 264: 177-186.
24. Rotimi CN, Jorde LB. Ancestry and disease in the age of genomic medicine. N Engl J Med 2010; 363: 1551-1558.
25. The Wellcome Trust Case Control Consortium. Genome-wide association study of 14000 cases of seven common diseases and 3000 shared controls. Nature 2007; 447: 661-678.
26. Plantinga LC, Crews DC, Coresh J, Miller ER 3rd, Saran R, Yee J, etal.; CDC CKD Surveillance Team. Prevalence of chronic kidney disease in US adults with undiagnosed diabetes or prediabetes. Clin J Am Soc Nephrol 2010; 5: 673-682.